March 4, 2021
Korea Newswire
DoseMe is a healthcare platform that allows clinicians to estimate patient's drug dosage level based on medical data and laboratory results. Read more
DoseMe is a healthcare platform that allows clinicians to estimate patient's drug dosage level based on medical data and laboratory results. Read more
CEO
Charles Cornish
Syapse is seen as one of DoseMe's top competitors. Syapse's headquarters is in San Francisco, California, and was founded in 2008. Syapse competes in the Internet Software industry. Syapse generates 381% of DoseMe's revenue.
March 4, 2021
Korea Newswire
March 3, 2021
PR Newswire
No recent acquisitions found related to DoseMe
Since DoseMe was founded in 2012, it has participated in 2 rounds of funding. In total DoseMe has raised $3.1M. DoseMe's last funding round was on Aug 2016 for a total of $2.6M
Since DoseMe was founded in 2012, it has participated in 2 rounds of funding. In total DoseMe has raised $3.1M. DoseMe's last funding round was on Aug 2016 for a total of $2.6M
No recent investments found related to DoseMe